Global Health Roundup: Cancer Vaccine Breakthrough, New Virus Alert and NHS Crisis Dominate Latest Developments

Oct 23 – A personalised cancer vaccine has shown it can cut the risk of disease returning, France has recorded the first human case of the Shamonda virus, and children in England face worsening NHS waiting times, as a series of significant health developments emerged this week across science, public health and healthcare systems.

Scientists announced on Oct. 23 that a personalised cancer vaccine has successfully reduced the likelihood of cancer returning in a major clinical trial, according to BBC News. Researchers described the results as a potential turning point in cancer treatment, saying the findings bring personalised medicine meaningfully closer to widespread use. The development arrives alongside news from India, where the government moved to slash prices on 137 cancer drugs from next month after the country's supreme court ruled that hospital and pharmacist mark-ups amounted to extortion, The Guardian reported. The case was originally filed in 2022 by a retired bank clerk who could not afford her medication, and the ruling is expected to benefit millions of patients who previously faced debt, land sales or foregone treatment to cover the cost of cancer medicines.

France is meanwhile investigating the death of a man who became the first human known to have contracted Shamonda virus, officials confirmed on Oct. 22, according to both BBC News and The Guardian. Shamonda virus is a type of bunyavirus transmitted through bites from infected midges and is typically found in livestock including cattle, sheep and goats, where it can cause diarrhoea, loss of appetite, reduced milk yield and congenital abnormalities in newborns. Authorities said investigations are ongoing to determine whether the virus contributed to the man's death in early October.

In England, thousands of children are facing some of the sharpest rises in NHS waiting times in the health service's history, according to an annual state of care report by the Care Quality Commission cited by The Guardian. The report found that while some adult waiting times have improved, children and young people are being hit hardest by soaring demand and falling staff numbers, with long delays making conditions harder to treat and significant regional disparities in care quality emerging across the country. Separately, British lawmakers called on the government to expand access to weight-loss injections on the NHS, saying current plans for only six percent of eligible patients to receive the drug Mounjaro by 2028 are unambitious, BBC News reported.

Concerns about the structural integrity of England's care sector also surfaced this week, with regulators warning that rapid acquisition of UK care homes by large private firms, including US investors, poses a risk to plans for a National Care Service, according to BBC News. The regulator said it is watching the situation carefully as home help services also fragment across the country.

Taken together, the developments reflect a week of contrasting signals in global health: scientific progress on cancer treatment running alongside systemic pressures on public healthcare systems and emerging infectious disease threats requiring close monitoring.